About the Authors
- Stephen R. Knight
-
Affiliation Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, United Kingdom
- Gabriel C. Oniscu
-
Affiliation Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, United Kingdom
- Luke Devey
-
Affiliation Pipeline Futures Group, GSK, 1250 South Collegeville Rd, Collegeville, Pennsylvania, 19426, United States of America
- Kenneth J. Simpson
-
Affiliation Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, United Kingdom
- Stephen J. Wigmore
-
Affiliation Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, United Kingdom
- Ewen M. Harrison
-
* E-mail: ewen.harrison@ed.ac.uk
Affiliation Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, United Kingdom
Competing Interests
LD is currently the Director of translational medicine for GlaxoSmithKline, two further authors have performed consultancy for GlaxoSmithKline (SJW and EMH), while two authors have received support from Astellas (GCO and KJS). The remaining authors have no conflicts of interest to declare. This does not alter the authors' adherence to PLOS ONE policies on data sharing and materials.
Author Contributions
Conceived and designed the experiments: SRK GCO LD KJS SJW EMH. Performed the experiments: SRK EMH. Analyzed the data: SRK EMH. Contributed reagents/materials/analysis tools: SRK EMH. Wrote the paper: SRK GCO LD KJS SJW EMH. Main manuscript authors: SRK EMH.